Notes - Segment Information, Etc.

Kringle Pharma,Inc. - Filing #7290853

Concept 2023-10-01 to
2024-09-30
Notes - Segment information, etc.
Notes - Segment information, etc.
Segment information
Description of fact that company's business comprises single segment
当社の事業セグメントは医薬品開発事業のみの単一セグメントであるため、記載を省略しております。

Talk to a Data Expert

Have a question? We'll get back to you promptly.